Head and neck squamous cell carcinoma (HNSCC) is a term collectively used to describe
all cancers that develop in the oral and nasal cavities, the paranasal sinuses, the salivary …

In the era of 'precision medicine', liquid biopsies based on cell-free DNA (cfDNA) have
emerged as a promising tool in the oncology field. cfDNA from cancer patients is a mixture of …

Cholangiocarcinomas (CHOLs), hepatobiliary malignancies, are characterized by high
genetic heterogeneity, a rich tumor microenvironment, therapeutic resistance, difficulty …

G protein-coupled receptors (GPCRs) are the largest drug target family. Unfortunately,
applications of GPCRs in cancer therapy are scarce due to very limited knowledge …

Head and neck squamous carcinoma (HNSCC) constitutes the sixth most prevalent cancer
worldwide. The molecular pathogenesis of HNSCC includes disorders in cell cycle …

The MAL gene encodes a 17-kDa protein containing four putative transmembrane segments
whose expression is restricted to human T cells, polarized epithelial cells and myelin …

Head and neck cancer, one of the most commonly prevalent malignancies globally is a
complex category of tumours that comprises cancers of the oral cavity, pharynx, and larynx …

Head and neck squamous cell carcinoma (HNSCC), especially oropharyngeal squamous
cell carcinoma (OPSCC), has recently been found to be significantly associated with human …

Biomarkers are crucial in oncology, from detection and monitoring to guiding management
and predicting treatment outcomes. Histological assessment of tissue biopsies is currently …

In the course of identifying the molecular mechanism that is related to strong cell‐cell
adhesion in stratified structures of the squamous epithelium, calmodulin‐like protein 5 …